生命科学资讯

Health AI dispatch from SF

China is taking on the world’s 10 most expensive medicines

Merck KGaA drops two cancer trials on assets from SpringWorks deal

Novo Nordisk details Irish expansion; EuroAPI’s challenges continue

How hospitals have shifted from experimenting with AI to justifying its cost

Yale’s Craig Crews builds model to guide biotech startups out of academia’s ‘valley of death’

FDA's top operating official Butler to retire, deputy to take over in April

Bayer continues trimming workforce; AnaptysBio's spinoff is named

BIO chief still backs FDA's Makary despite 'head-scratcher' decisions

Sanofi licenses Sino Biopharm’s transplant drug for $135M upfront

UCB boards T cell engager train in $60M upfront deal with Antengene

Blackstone to support Teva on Sanofi-partnered TL1A with $400M

Moderna will pay $950M to settle Covid vaccine patent claims with Arbutus, Roivant

Old school healthcare is warming up to tech

Prime Medicine reverses course to seek FDA approval of shelved therapy

After years of dispute with FDA, Vanda will get a public hearing for jet lag drug

Kyowa Kirin ends OX40 trials after Amgen balked, safety concern

FDA explains how some copycat drugs can still win three years of exclusivity

EveryOne Medicines shuts down, ending custom cure venture that banked on new FDA pathway

Prolium's $50M Series A raise; COUR Pharma touts liver drug follow-up